Does Medicaid cover Mounjaro
This brief describes current coverage of GLP-1s in Medicare and Medicaid, the Centers for Medicare & Medicaid Services (CMS) efforts to expand access and lower costs for GLP-1s through temporary demonstration programs, and potential impacts on beneficiaries and program budgets
For guidance on transitioning between GLP-1 drugs, see semaglutide to tirzepatide switching
At baseline, in Trials 1 and 2, the mean AHI was 51.5 and 49.5 events/hour, respectively, and the mean BMI was 39.1 kg/m 2 and 38.7 kg/m 2 , respectively
Although data are lacking to justify the cessation of GLP-1 RAs therapy preoperatively, additional precautions should be taken due to aspiration risk
Rather than avoiding these medications, should focus on good hydration and other kidney stone prevention measures